Zobrazeno 1 - 10
of 89
pro vyhledávání: '"De Socio, G. V."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Taramasso L., Bonfanti P., Ricci E., Maggi P., Orofino G., Squillace N., Menzaghi B., Madeddu G., Molteni C., Vichi F., Riguccini E., Saracino A., Santoro C., Guastavigna M., Francisci D., Di Biagio A., De Socio G. V., Sarchi E., Chichino G., Bolla C., Bellacosa C., Angarano G., Calza L., Farinazzo M., Angioni G., Gussio M., Celesia B. M., Falasca K., Mastroianni A., Guadagnino G., Salomoni E., Martinelli C., Dentone C., Bassetti M., Cenderello G., Pellicano G. F., Nunnari G., Valsecchi L., Cordier L., Parisini S., Rizzardini G., Rusconi S., Conti F., Bandera A., Gori A., Motta D., Puoti M., Migliorino G. M., Martini S., Cascio A., Trizzino M., Gulminetti R., Nofri M., Cibelli D., Parruti G., Mameli M. S.
Publikováno v:
HIV Medicine. 23:70-79
Objectives: The aim of this study was to assess the incidence of being overweight and metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross-sectional studies conducted over three different periods: 2005, 2011 and 2015.
Autor:
Schiaroli, E., De Socio, G. V., Gidari, A., Malincarne, L., Benedetti, S., Lanzi, A., Bastianelli, S., Pierucci, S., Busti, C., Fagotti, B., Vicenti, I., Zazzi, M., Francisci, D.
Publikováno v:
Mediterranean journal of hematology and infectious diseases. 14(1)
In patients with mild-to-moderate COVID-19 and at high risk of progression, casirivimab/imdevimab and bamlanivimab/etesivimab were utilized in Umbria from late April to November 2021. This period was characterized by an initial prevalence of alpha (B
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
De Socio, G. V., Pasqualini, M., Ricci, E., Maggi, P., Orofino, G., Squillace, N., Menzaghi, B., Madeddu, G., Taramasso, L., Francisci, D., Bonfanti, P., Vichi, F., Dell'Omo, M., Pieroni, L., Santoro, C., Quirino, T., Farinazzo, M., Magne, F., Molteni, C., Malincarne, L., Riguccini, E., Nofri, M., Bagella, P., Mameli, M. S., Tiri, B., Guastavigna, M.
Publikováno v:
BMC Public Health
BMC Public Health, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Public Health, Vol 20, Iss 1, Pp 1-10 (2020)
Background Tobacco use is a leading cause of preventable diseases and death for all individuals, even more so for people living with HIV (PLWH), due to their status of chronic inflammation. To date, in Italy no study was performed to compare smoking
Autor:
De Socio, G. V., Malincarne, L., Arena, S., Troiani, S., Benedetti, S., Camilloni, B., Epicoco, G., Mencacci, A., Francisci, D.
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases, Vol 12, Iss 1 (2020)
Mediterranean Journal of Hematology and Infectious Diseases, Vol 12, Iss 1 (2020)
We report a case of a 33-year-old Italian pregnant at 40 weeks of gestation affected by asymptomatic SARS-CoV-2 infection delivering a healthy baby with no evidence of Coronavirus Disease 2019 (COVID-19). Vaginal delivery was uncomplicated, the breas
Autor:
Bonfanti, P., De Vito, A., Ricci, E., Menzaghi, B., Orofino, G., Squillace, N., Molteni, C., De Socio, G. V., Salomoni, E., Celesia, B. M., Dentone, C., Colombo, V., Madeddu, G, Nunnari, G., Pellicanò, G. F.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3978::cce2a22e81402683c9f3d42cfcce16f7
http://hdl.handle.net/11570/3174056
http://hdl.handle.net/11570/3174056
Autor:
Taramasso, L., Tatarelli, Paola, Ricci, Elena, Madeddu, G., Menzaghi, B., Squillace, Nicola, De Socio, G. V., Martinelli, C., Gulminetti, Roberto, Maggi, P., Orofino, G., Vichi, F., Di Biagio, A., Bonfanti, Paolo, Bellacosa, C., Calza, L., Abeli, C., Celesia, B. M., Grosso, C., Stagno, A., Mazzotta, F., Penco, G., Cassola, G., Nicolini, L. A., Dentone, C., Molteni, C., Palvarini, L., Scalzini, A., Carenzi, L., Rizzardini, G., Valsecchi, L., Cordier, L., Rusconi, S., Colombo, Valeria, Galli, M., Franzetti, M., Sgrelli, A., Mazzotta, E., Parruti, G., Bagella, P., Mura, M. S., Libertone, R., Antinori, A., Di Giambenedetto, S., Guastavigna, M., Caramello, P.
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-8 (2018)
Background: Dyslipidemia represents a significant non-infectious comorbidity among people living with HIV. The aim of this study is to evaluate the impact on lipid profile of switches from an efavirenz (EFV) or protease inhibitor/ritonavir (PI/r)-bas
Autor:
Taramasso, L., Bonfanti, P., Ricci, E., Squillace, N., Menzaghi, B., Madeddu, G., De Socio, G. V., Orofino, G., Celesia, B. M., Pellicanò, G. F., Gulminetti, R., Martinelli, C., Vichi, F., Cenderello, G., Maggi, P., Angioni, G., Rusconi, S., Parruti, G., Bandera, A., Gori, A., A. Di Biagio.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3978::78449a15493b0e2201875d711a7a9904
http://hdl.handle.net/11570/3147219
http://hdl.handle.net/11570/3147219